» Articles » PMID: 37542715

Protocol for Establishing a Coculture with Fibroblasts and Colorectal Cancer Organoids

Overview
Journal STAR Protoc
Publisher Cell Press
Date 2023 Aug 5
PMID 37542715
Authors
Affiliations
Soon will be listed here.
Abstract

The tumor microenvironment is essential for mediating drug resistance and tumor progression. Here, we present a coculture system, which enables drug testing of colorectal cancer organoids and fibroblasts without additional matrix components such as Matrigel or basement membrane extracts. First, we describe steps to use a readout for high-throughput drug testing using a luminescence-based viability assay. Second, we detail a readout that uses flow cytometry to distinguish toxic effects on either colorectal cancer organoids or fibroblasts.

Citing Articles

Patient-Derived Tumor Organoids: A Platform for Precision Therapy of Colorectal Cancer.

Li Y, Wu W, Yao J, Wang S, Wu X, Yan J Cell Transplant. 2025; 34:9636897251314645.

PMID: 39953837 PMC: 11829288. DOI: 10.1177/09636897251314645.


Model systems to study tumor-microbiome interactions in early-onset colorectal cancer.

Richter K, Wrage M, Krekeler C, De Oliveira T, Conradi L, Menck K EMBO Mol Med. 2025; 17(3):395-413.

PMID: 39948421 PMC: 11903813. DOI: 10.1038/s44321-025-00198-3.


Harnessing 3D models to uncover the mechanisms driving infectious and inflammatory disease in the intestine.

Micati D, Hlavca S, Chan W, Abud H BMC Biol. 2024; 22(1):300.

PMID: 39736603 PMC: 11686917. DOI: 10.1186/s12915-024-02092-9.


Advancements in 3D In Vitro Models for Colorectal Cancer.

Vitale S, Calapa F, Colonna F, Luongo F, Biffoni M, De Maria R Adv Sci (Weinh). 2024; 11(32):e2405084.

PMID: 38962943 PMC: 11348154. DOI: 10.1002/advs.202405084.